GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
NCT00567424
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
No longer viable
Conditions
Epilepsy
Interventions
DRUG:
GW273225
Sponsor
GlaxoSmithKline